DK1603580T3 - Præparat til indgivelse af jern til behandling af Restless Legs Syndrom - Google Patents

Præparat til indgivelse af jern til behandling af Restless Legs Syndrom

Info

Publication number
DK1603580T3
DK1603580T3 DK03816391T DK03816391T DK1603580T3 DK 1603580 T3 DK1603580 T3 DK 1603580T3 DK 03816391 T DK03816391 T DK 03816391T DK 03816391 T DK03816391 T DK 03816391T DK 1603580 T3 DK1603580 T3 DK 1603580T3
Authority
DK
Denmark
Prior art keywords
preparation
treatment
restless legs
legs syndrome
iron administration
Prior art date
Application number
DK03816391T
Other languages
English (en)
Inventor
Mary Jane Helenek
Ralf A Lange
Marc L Tokars
Fred B Oldham
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Application granted granted Critical
Publication of DK1603580T3 publication Critical patent/DK1603580T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Plant Substances (AREA)
DK03816391T 2003-03-14 2003-05-13 Præparat til indgivelse af jern til behandling af Restless Legs Syndrom DK1603580T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/389,228 US6960571B2 (en) 2003-03-14 2003-03-14 Methods and compositions for administration of iron for the treatment of restless leg syndrome
PCT/US2003/015087 WO2004082693A1 (en) 2003-03-14 2003-05-13 Composition for administration of iron for the treatment of restless legs syndrome

Publications (1)

Publication Number Publication Date
DK1603580T3 true DK1603580T3 (da) 2008-10-06

Family

ID=32962229

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03816391T DK1603580T3 (da) 2003-03-14 2003-05-13 Præparat til indgivelse af jern til behandling af Restless Legs Syndrom

Country Status (26)

Country Link
US (1) US6960571B2 (da)
EP (1) EP1603580B1 (da)
JP (2) JP2006520322A (da)
KR (1) KR100978377B1 (da)
CN (1) CN1771044B (da)
AT (1) ATE400280T1 (da)
AU (1) AU2003249635C1 (da)
BR (1) BR0318185A (da)
CA (1) CA2518971C (da)
CY (1) CY1110407T1 (da)
DE (1) DE60322121D1 (da)
DK (1) DK1603580T3 (da)
ES (1) ES2309403T3 (da)
HK (1) HK1089666A1 (da)
HR (1) HRP20050796A2 (da)
IL (1) IL170386A (da)
MX (1) MXPA05009786A (da)
NO (1) NO20054728L (da)
PL (1) PL206810B1 (da)
PT (1) PT1603580E (da)
RS (1) RS51823B (da)
RU (1) RU2319490C2 (da)
SI (1) SI1603580T1 (da)
UA (1) UA83483C2 (da)
WO (1) WO2004082693A1 (da)
ZA (1) ZA200508308B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060116349A1 (en) * 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
EP1655040A1 (en) * 2004-10-08 2006-05-10 Bracco Imaging, S.P.A. Contrast agent formulations for the visualization of the lymphatic system
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
JP2009520023A (ja) * 2005-12-20 2009-05-21 セリュウサイエンス エイビー 下肢静止不能症候群を治療及び診断するための方法及び組成物
AU2006331590B2 (en) * 2005-12-23 2012-07-26 Ajay Gupta Parenteral nutrition composition containing iron
WO2007081744A2 (en) 2006-01-06 2007-07-19 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
AU2013206429B2 (en) * 2006-01-06 2016-04-28 Vifor (International) Ag Methods and compositions for administration of iron
AU2016205002C1 (en) * 2006-01-06 2020-09-24 Vifor (International) Ag Methods and compositions for administration of iron
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
EP1941869A1 (en) * 2007-01-04 2008-07-09 Vifor (International) Ag Multicompartment bag for storage of iron preparations
JP2011516419A (ja) * 2008-03-28 2011-05-26 カイナ エルエルシー 鉄欠乏性障害を治療するためのフェリチンの使用
AU2009248885B2 (en) * 2008-05-23 2015-02-05 Hospira, Inc. Packaged iron sucrose products
CN102395595A (zh) * 2008-11-06 2012-03-28 生物链接治疗股份有限公司 不宁腿综合症和睡眠障碍的治疗
PT2411053T (pt) 2009-03-25 2017-02-15 Pharmacosmos Holding As Composto oligossacarídico de ferro estável
US8058076B2 (en) * 2009-03-31 2011-11-15 Astron Research Limited In-vitro method for testing bioequivalence of iron-sucrose formulation
CN102440999A (zh) * 2010-10-15 2012-05-09 天津瑞普生物技术股份有限公司 一种用于防治仔猪缺铁性贫血、低过敏反应的复方药物
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
CA2904357C (en) 2013-03-15 2020-09-22 Intrinsic Lifesciences Llc Anti-hepcidin antibodies and uses thereof
JP2014132029A (ja) * 2014-04-03 2014-07-17 Chyna Llc 鉄欠乏性障害を治療するためのフェリチンの使用
US10323088B2 (en) 2014-09-22 2019-06-18 Intrinsic Lifesciences Llc Humanized anti-hepcidin antibodies and uses thereof
WO2016069950A2 (en) * 2014-10-29 2016-05-06 University Of Utah Research Foundation Methods of treating hypoxia-associated optical conditions with cartilage oligo matrix protein-angiopoietin 1 (comp-ang1)
EP2913054A1 (en) 2015-03-19 2015-09-02 Pharmacosmos Holding A/s Iron carbohydrate complex for treatment of restless leg syndrome (rls)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248492A (en) * 1986-07-03 1993-09-28 Advanced Magnetics, Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US5700832A (en) * 1994-10-19 1997-12-23 Daewon Pharm. Co., Ltd. Antianemic agent containing iron and difructose
SE9803760D0 (sv) 1998-11-04 1998-11-04 Jan Hedner Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
US6611707B1 (en) * 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
WO2001074162A1 (en) 2000-04-04 2001-10-11 The Regents Of The University Of California Treatment of sleep disorders with hypocretin-1

Also Published As

Publication number Publication date
ZA200508308B (en) 2006-10-25
RS51823B (sr) 2012-02-29
US20040180849A1 (en) 2004-09-16
JP2010180252A (ja) 2010-08-19
PL206810B1 (pl) 2010-09-30
MXPA05009786A (es) 2006-03-08
KR100978377B1 (ko) 2010-08-30
UA83483C2 (uk) 2008-07-25
HRP20050796A2 (en) 2005-12-31
PL378875A1 (pl) 2006-05-29
RU2005131832A (ru) 2006-03-20
AU2003249635B2 (en) 2009-06-04
NO20054728D0 (no) 2005-10-13
IL170386A (en) 2013-03-24
ATE400280T1 (de) 2008-07-15
CA2518971A1 (en) 2004-09-30
NO20054728L (no) 2005-12-13
BR0318185A (pt) 2006-03-21
RU2319490C2 (ru) 2008-03-20
CA2518971C (en) 2009-02-17
SI1603580T1 (sl) 2009-04-30
EP1603580B1 (en) 2008-07-09
RS20050695A (en) 2008-04-04
AU2003249635A1 (en) 2004-10-11
US6960571B2 (en) 2005-11-01
CY1110407T1 (el) 2015-04-29
DE60322121D1 (de) 2008-08-21
JP2006520322A (ja) 2006-09-07
EP1603580A1 (en) 2005-12-14
AU2003249635C1 (en) 2009-11-05
PT1603580E (pt) 2008-09-10
KR20060082032A (ko) 2006-07-14
CN1771044B (zh) 2012-09-19
ES2309403T3 (es) 2008-12-16
CN1771044A (zh) 2006-05-10
WO2004082693A1 (en) 2004-09-30
HK1089666A1 (en) 2006-12-08

Similar Documents

Publication Publication Date Title
DK1603580T3 (da) Præparat til indgivelse af jern til behandling af Restless Legs Syndrom
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
DK1505990T3 (da) Fremgangsmåder til behandling af hepatitis
SG146643A1 (en) Treating or preventing restless legs syndrome using prodrugs of gaba analogs
DE602005024571D1 (de) Opioide zur behandlung von ruhelosigkeit in den unteren gliedmassen
DK1501499T3 (da) Transepikutan indgivelsesform til behandling af restless legs-syndromet
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
MX2007004955A (es) Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
WO2007055804A3 (en) Methods and compositions for administration of iron for the treatment of restless leg syndrome
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
DK1030667T3 (da) Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö
NO20062570L (no) Imidazo[1,2-A] pyridin derivater for behandling av stille gastroosofagial refluks
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
SE0301947D0 (sv) New method and uses
FR2860234B1 (fr) Nouveaux derives 666 du thioxylose
RU2013148539A (ru) Алиспоривир для лечения инфекции вируса гепатита с
EA200701010A1 (ru) Препарат гепирона с высокой дозировкой и длительным высвобождением
ATE454144T1 (de) Behandlung von malignen neoplasien
ATE425755T1 (de) 4-aminophenyl-morpholinon-derivate zur behandlung von hepatitis c
DK1677808T3 (da) Kombinationspræparat til behanding af sepsis
RU2004104555A (ru) Способ лечения диабетической ретинопатии, осложненной гемофтальмом
UA50298A (uk) Спосіб лікування синдрому діабетичної стопи
DK1311286T3 (da) Behandling af hepatitis C med thymosin og pegyleret interferon
UA43765U (ru) Способ лечения патологической зависимости от летучих растворителей у детей и подростков